Variants near the HLA complex group 22 gene (HCG22) confer increased susceptibility to late-onset asthma in Japanese populations

Yohei Yatagai; Tomomitsu Hirota; Tohru Sakamoto; Hideyasu Yamada; Hironori Masuko; Yoshiko Kaneko; Hiroaki Iijima; Takashi Naito; Emiko Noguchi; Mayumi Tamari; Michiaki Kubo; Atsushi Takahashi; Satoshi Konno; Hironi Makita; Masaharu Nishimura; Minako Hijikata; Naoto Keicho; Sakae Homma; Yoshio Taguchi; Arata Azuma; Shoji Kudoh; Nobuyuki Hizawa

doi:10.1016/j.jaci.2015.11.023

Variants near the HLA complex group 22 gene (HCG22) confer increased susceptibility to late-onset asthma in Japanese populations

Yohei Yatagai, Tomomitsu Hirota, Tohru Sakamoto, Hideyasu Yamada, Hironori Masuko, Yoshiko Kaneko, Hiroaki Iijima, Takashi Naito, Emiko Noguchi, Mayumi Tamari, Michiaki Kubo, Atsushi Takahashi, Satoshi Konno, Hironi Makita, Masaharu Nishimura, Minako Hijikata, Naoto Keicho, Sakae Homma, Yoshio Taguchi, Arata AzumaShoji Kudoh, Nobuyuki Hizawa

Research output: Contribution to journal › Article › peer-review

22 Citations (Scopus)

Original language	English
Pages (from-to)	281-283.e13
Journal	Journal of Allergy and Clinical Immunology
Volume	138
Issue number	1
DOIs	https://doi.org/10.1016/j.jaci.2015.11.023
Publication status	Published - 01-07-2016
Externally published	Yes

All Science Journal Classification (ASJC) codes

Immunology and Allergy
Immunology

Access to Document

10.1016/j.jaci.2015.11.023

Cite this

Yatagai, Y., Hirota, T., Sakamoto, T., Yamada, H., Masuko, H., Kaneko, Y., Iijima, H., Naito, T., Noguchi, E., Tamari, M., Kubo, M., Takahashi, A., Konno, S., Makita, H., Nishimura, M., Hijikata, M., Keicho, N., Homma, S., Taguchi, Y., ... Hizawa, N. (2016). Variants near the HLA complex group 22 gene (HCG22) confer increased susceptibility to late-onset asthma in Japanese populations. Journal of Allergy and Clinical Immunology, 138(1), 281-283.e13. https://doi.org/10.1016/j.jaci.2015.11.023

@article{a899a488161d4866be1fa95711da9e7a,

title = "Variants near the HLA complex group 22 gene (HCG22) confer increased susceptibility to late-onset asthma in Japanese populations",

author = "Yohei Yatagai and Tomomitsu Hirota and Tohru Sakamoto and Hideyasu Yamada and Hironori Masuko and Yoshiko Kaneko and Hiroaki Iijima and Takashi Naito and Emiko Noguchi and Mayumi Tamari and Michiaki Kubo and Atsushi Takahashi and Satoshi Konno and Hironi Makita and Masaharu Nishimura and Minako Hijikata and Naoto Keicho and Sakae Homma and Yoshio Taguchi and Arata Azuma and Shoji Kudoh and Nobuyuki Hizawa",

note = "Funding Information: This study was partly supported by a Grant-in-Aid for Scientific Research (B; no. 24390206 ) from the Japan Society for the Promotion of Science , the Practical Research Project for Rare Intractable Diseases from Japan Agency for Medical Research and Development (AMED), and a grant from the Ministry of Health, Labour and Welfare of Japan awarded to the Study Group on Diffuse Pulmonary Disorders, Scientific Research/Research on intractable diseases. Funding Information: Disclosure of potential conflict of interest: T. Sakamoto has received research support from GlaxoSmithKline and has received lecture fees from Astellace, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Kyorin, MSD, and Novartis. H. Iijima has received lecture fees from Astellace, AstraZeneca, Kyorin, and Novartis. M. Nishimura has received research support from Nippon Boehringer Ingelheim and Pfizer Japan. N. Hizawa is on the GlaxoSmithKline advisory board; has received research support from Astellace, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Kyorin, MSD, Novartis, and Chugai Pharmaceutical; and has received lecture fees from Astellace, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Kyorin, MSD, and Novartis. The rest of the authors declare that they have no relevant conflicts of interest. Letter to the editor ",

year = "2016",

month = jul,

day = "1",

doi = "10.1016/j.jaci.2015.11.023",

language = "English",

volume = "138",

pages = "281--283.e13",

journal = "Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

publisher = "Elsevier Inc.",

number = "1",

}

Yatagai, Y, Hirota, T, Sakamoto, T, Yamada, H, Masuko, H, Kaneko, Y, Iijima, H, Naito, T, Noguchi, E, Tamari, M, Kubo, M, Takahashi, A, Konno, S, Makita, H, Nishimura, M, Hijikata, M, Keicho, N, Homma, S, Taguchi, Y, Azuma, A, Kudoh, S & Hizawa, N 2016, 'Variants near the HLA complex group 22 gene (HCG22) confer increased susceptibility to late-onset asthma in Japanese populations', Journal of Allergy and Clinical Immunology, vol. 138, no. 1, pp. 281-283.e13. https://doi.org/10.1016/j.jaci.2015.11.023

TY - JOUR

T1 - Variants near the HLA complex group 22 gene (HCG22) confer increased susceptibility to late-onset asthma in Japanese populations

AU - Yatagai, Yohei

AU - Hirota, Tomomitsu

AU - Sakamoto, Tohru

AU - Yamada, Hideyasu

AU - Masuko, Hironori

AU - Kaneko, Yoshiko

AU - Iijima, Hiroaki

AU - Naito, Takashi

AU - Noguchi, Emiko

AU - Tamari, Mayumi

AU - Kubo, Michiaki

AU - Takahashi, Atsushi

AU - Konno, Satoshi

AU - Makita, Hironi

AU - Nishimura, Masaharu

AU - Hijikata, Minako

AU - Keicho, Naoto

AU - Homma, Sakae

AU - Taguchi, Yoshio

AU - Azuma, Arata

AU - Kudoh, Shoji

AU - Hizawa, Nobuyuki

N1 - Funding Information: This study was partly supported by a Grant-in-Aid for Scientific Research (B; no. 24390206 ) from the Japan Society for the Promotion of Science , the Practical Research Project for Rare Intractable Diseases from Japan Agency for Medical Research and Development (AMED), and a grant from the Ministry of Health, Labour and Welfare of Japan awarded to the Study Group on Diffuse Pulmonary Disorders, Scientific Research/Research on intractable diseases. Funding Information: Disclosure of potential conflict of interest: T. Sakamoto has received research support from GlaxoSmithKline and has received lecture fees from Astellace, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Kyorin, MSD, and Novartis. H. Iijima has received lecture fees from Astellace, AstraZeneca, Kyorin, and Novartis. M. Nishimura has received research support from Nippon Boehringer Ingelheim and Pfizer Japan. N. Hizawa is on the GlaxoSmithKline advisory board; has received research support from Astellace, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Kyorin, MSD, Novartis, and Chugai Pharmaceutical; and has received lecture fees from Astellace, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Kyorin, MSD, and Novartis. The rest of the authors declare that they have no relevant conflicts of interest. Letter to the editor

PY - 2016/7/1

Y1 - 2016/7/1

UR - http://www.scopus.com/inward/record.url?scp=84961839293&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961839293&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2015.11.023

DO - 10.1016/j.jaci.2015.11.023

M3 - Article

C2 - 26830115

AN - SCOPUS:84961839293

SN - 0091-6749

VL - 138

SP - 281-283.e13

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

IS - 1

ER -

Variants near the HLA complex group 22 gene (HCG22) confer increased susceptibility to late-onset asthma in Japanese populations

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this